Unicycive Therapeutics, Inc.
NASDAQ:UNCY · NASDAQ Capital Market
-$0.24 today
Vol 1.45M · Avg 0.65M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+8.04%
Period High
$8.56
Period Low
$3.74
Latest
$6.85
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Relmada Therapeutics, Inc.
NASDAQ:RLMD
$483.64M
Immunic, Inc.
NASDAQ:IMUX
$140.03M
Vaxart, Inc.
NASDAQ:VXRT
$135.55M
Repare Therapeutics Inc.
RPTX
$114.24M
CAMP4 Therapeutics Corporation
NASDAQ:CAMP
$89.00M
MindWalk Holdings Corp.
NASDAQ:HYFT
$70.30M
Biomea Fusion, Inc.
NASDAQ:BMEA
$70.21M
Cibus, Inc.
NASDAQ:CBUS
$59.59M
PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
$59.46M
Acrivon Therapeutics, Inc. Common Stock
ACRV
$48.75M
What is the latest UNCY filing?
The latest filing shown is 4/A dated Jun 15, 2026.
How many recent filings does UNCY have?
Intrinsic Alpha currently shows 20 recent filings for UNCY.
Explore More
Continue the stock analysis
Jump to another research area for this company.